We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News   Oct 19, 2017

 
Quotient Clinical Signs Cocrystal Agreement with Nuformix
 
 
 

RELATED ARTICLES

Compound Kills Chemotherapy-resistant Cancer Cells

News

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

How Does DEET Keep Mosquitoes at Bay?

News

Since its invention during WWII, researchers have been trying to pinpoint precisely how DEET actually affects mosquitos. New research suggests DEET may chemically “cloak” humans from malaria-carrying mosquitos, rather than repel them.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE